GERM — Amplify Treatments Testing and Advancements ETF
Amplify Treatments Testing and Advancements ETF (ticker: GERM) is a equity ETF issued by Amplify Investments tracking Prime Treatments, Testing and Advancements Index. It was launched on 2020-06-17.
About GERM
The Amplify Treatments Testing and Advancements ETF (GERM) is an equity-based fund tracking the Prime Treatments, Testing and Advancements Index. It invests in U.S. companies within the pharmaceutical, biotechnology, and life sciences sectors. GERM provides exposure to a broad segment of the healthcare industry, focusing on companies involved in medical treatments, testing, and advancements. Investors seeking targeted exposure to this sector may consider GERM.
- Tracks the Prime Treatments, Testing and Advancements Index.
- Invests in U.S. Pharma, Biotech & Life Sciences companies.
- Expense ratio of 0.01%.
Returns (Total Return)
| Period | Return |
|---|---|
| 1 Day | -0.29% |
| 1 Week | 0.75% |
| 1 Month | 3.78% |
| 3 Months | -4.71% |
| 6 Months | 6.97% |
| YTD | — |
| 1 Year | — |
| 3 Years | — |
| 5 Years | — |
| 10 Years | — |
| Since Inception | — |
Fund Profile
| Issuer | Amplify Investments |
|---|---|
| Brand | Amplify |
| Asset Class | equity |
| Strategy | Vanilla |
| Structure | ETF |
| Category | Sector |
| Segment | Equity: U.S. Pharma, Biotech & Life Sciences |
| Sector | Broad |
| Region | North America |
| Index Tracked | Prime Treatments, Testing and Advancements Index |
| Inception Date | 2020-06-17 |
| Tax on Distributions | Qualified dividends |
Quick Facts
| Ticker | GERM |
|---|---|
| Full Name | Amplify Treatments Testing and Advancements ETF |
| Issuer | Amplify Investments |
| Asset Class | equity |
| Expense Ratio | 0.01% |
| Inception | 2020-06-17 |
| Index Tracked | Prime Treatments, Testing and Advancements Index |
Frequently Asked Questions
What does GERM track?
GERM (Amplify Treatments Testing and Advancements ETF) tracks Prime Treatments, Testing and Advancements Index, a equity benchmark.
What is the expense ratio of GERM?
GERM has an expense ratio of 0.01% per year.
What is the AUM of GERM?
Assets under management for GERM are reported by Amplify Investments and updated regularly on this page.
Does GERM pay a dividend?
GERM distributes income according to its prospectus (Qualified dividends tax treatment). Check the dividend history tab for ex-dividend dates and yield.
Who issues GERM?
GERM is issued by Amplify Investments under the Amplify brand, launched on 2020-06-17.
Open the interactive GERM dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.